
Greenstone Biosciences and Intel Forge Strategic Alliance for AI-Powered Drug Discovery
In a significant move poised to redefine the landscape of pharmaceutical innovation, [Greenstone Biosciences, Inc.](https://greenstonebio.com/) has officially partnered with global technology powerhouse [Intel Corp.](https://www.intel.com/) to supercharge its AI-enabled drug discovery efforts. Announced on June 20, 2026, this collaboration brings together Greenstone's unique large-scale human biobank of induced pluripotent stem cells (iPSCs) with Intel's cutting-edge Edge AI advanced computing and artificial intelligence infrastructure. The alliance aims to dramatically accelerate the identification and development of novel therapeutic compounds.


















